Apparent efficacy of -opioid receptor ligands on serum prolactin levels in rhesus monkeys

Author： Butelman E.R. Harris T.J. Kreek M.-J.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.383, Iss.3, 1999-11, pp. : 305-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BW373U86, a -opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys

By Butelman E.R. Negus S.S. Gatch M.B. Chang K.-J. Woods J.H.

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 285-287

Elsevier

Access to resources Recommend Favorite

Interactions between ∆⁹-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

By Li Jun-Xu McMahon Lance Gerak Lisa Becker Ginger France Charles

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 199-208

Springer Publishing Company

Access to resources Recommend Favorite

Kappa-opioid receptor ligands

By Husbands Stephen M

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1725-1741

Informa Healthcare

Access to resources Recommend Favorite

Tritiated Opioid Receptor Ligands as Radiotracers

Current Pharmaceutical Design, Vol. 19, Iss. 42, 2013-12 ,pp. : 7461-7472

Bentham Science Publishers

Access to resources Recommend Favorite

Several -opioid receptor ligands display no subtype selectivity to the human -opioid receptor

By Parkhill A.L. Bidlack J.M.

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 257-264

Elsevier

Access to resources Recommend Favorite